2001

1. Efficacy and safety of tenecteplase in combination with enoxaparin, abciximab, or unfractionated heparin: The ASSENT-3 randomised trial in acute myocardial infarction

   Lancet, Vol. 358, Núm. 9282, pp. 605-613